Last news
Gibraltar BSN Leverages Chatbot Technology for Another Industry FIRST

Gibraltar BSN Leverages Chatbot Technology for Another Industry FIRST

...

DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE

DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE

...

The key vender of network communication, Z-COM, Inc. in Taiwan launched indoor-outdoor hybrid wireless network services for various venues on Chunghwa Telecom IMO platform

The key vender of network communication, Z-COM, Inc. in Taiwan launched indoor-outdoor hybrid wireless network services for various venues on Chunghwa Telecom IMO platform

...

SEA Electric Partners with Mack Trucks as a Tier 1 Supplier

SEA Electric Partners with Mack Trucks as a Tier 1 Supplier

...

BEST Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2022 Financial Results

BEST Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2022 Financial Results

...

Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas

Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas

...

Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

...

Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU

Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU

...

menu
menu